GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » PS Ratio

Sinphar Pharmaceutical Co (TPE:1734) PS Ratio : 1.82 (As of Dec. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sinphar Pharmaceutical Co's share price is NT$30.50. Sinphar Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$16.78. Hence, Sinphar Pharmaceutical Co's PS Ratio for today is 1.82.

Good Sign:

Sinphar Pharmaceutical Co Ltd stock PS Ratio (=1.83) is close to 3-year low of 1.69

The historical rank and industry rank for Sinphar Pharmaceutical Co's PS Ratio or its related term are showing as below:

TPE:1734' s PS Ratio Range Over the Past 10 Years
Min: 1.05   Med: 1.88   Max: 4.57
Current: 1.82

During the past 13 years, Sinphar Pharmaceutical Co's highest PS Ratio was 4.57. The lowest was 1.05. And the median was 1.88.

TPE:1734's PS Ratio is ranked better than
86.52% of 1016 companies
in the Biotechnology industry
Industry Median: 8.76 vs TPE:1734: 1.82

Sinphar Pharmaceutical Co's Revenue per Sharefor the three months ended in Sep. 2024 was NT$4.09. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$16.78.

Warning Sign:

Sinphar Pharmaceutical Co Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Sinphar Pharmaceutical Co was 2.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.50% per year.

During the past 13 years, Sinphar Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 8.50% per year. The lowest was -6.90% per year. And the median was 3.50% per year.

Back to Basics: PS Ratio


Sinphar Pharmaceutical Co PS Ratio Historical Data

The historical data trend for Sinphar Pharmaceutical Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co PS Ratio Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 2.17 1.99 1.95 1.93

Sinphar Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 1.93 2.05 2.16 1.95

Competitive Comparison of Sinphar Pharmaceutical Co's PS Ratio

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's PS Ratio falls into.



Sinphar Pharmaceutical Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Sinphar Pharmaceutical Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=30.50/16.779
=1.82

Sinphar Pharmaceutical Co's Share Price of today is NT$30.50.
Sinphar Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$16.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Sinphar Pharmaceutical Co  (TPE:1734) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Sinphar Pharmaceutical Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Sinphar Pharmaceutical Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinphar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines